SALL4 and hepatocellular carcinoma: Although the role of SALL4 was evaluated in HCC cell lines and it has been considered as a valuable biomarker and also as potential therapeutic target, the reports relating the SALL4 serological levels in HCC patients are scarce, especially in association with overall survival of HCC patients.